Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - October, 2004
40 articles
- Brand-Name Drug Makers Blame Patent Expirations For Depressed Profits
- Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs
- FDA Calls For Uniform Name For Biogenerics
- Ethypharm Sues Bentley Over Trade Secrets
- Flamel Withdraws Lawsuit Vs. Novo Nordisk
- Canadian Branded Drug Makers Miss R&D Target
- Bayer Takes License For Homocysteine Assay
- India Government Unveils Details Of Patent Regime Overhaul
- Swiss Activists Form Coalition To Oppose Proposed Patent Law Revisions
- Genentech Loses Appeal Of $500M Royalties Verdict
- U.S. Constitution Bars Canadian Drug Imports, Research Paper Argues
- Akzo Nobel To Pay $36M In Third Settlement Over Remeron Patent Evergreening
- U.K. House Of Lords Declares Amgen's Erythropoietin Patent Invalid
- India To Overhaul Patent Regime During Parliament's Winter Session
- AFL-CIO Sues AstraZeneca Over Handling Of Prilosec Patent Expiration
- Bausch & Lomb Unit Sued Over Patent For Vitrectomy Cutter
- Duane Morris Hires Former Kenyon Partner
- U.S., Israeli Negotiators Make Progress In Talks On Drug IP Rights
- Judge Rules TKT Infringes Amgen Erythropoietin Patents
- J&J Unit Sues St. Jude Medical Unit Over Medical Device Patents
- Israel Provoking Global Drug Patent Dispute, E.U. Warns
- Artes Medical Asks EPO, USPTO To Revoke Patents For Sanofi-Aventis Lipoatrophy Treatment
- Judge Clears Alpharma's Generic Neurontin
- Judge Enters Permanent Injunction Vs. Medtronic Units In Patent Suit
- Bingham Hires Two Venable IP Partners
- Jury Orders Medtronic Unit To Pay $400M In Punitive Damages In Patent Suit
- Tyco Healthcare Unit Sues J&J Unit Over Surgical Scalpel Patents
- U.S., Israeli Officials To Tackle Dispute Over Drug Data Exclusivity
- Hatch, Waxman Signal Concern About "Authorized Generics"
- In Risky Move, Alpharma Launches Generic Neurontin
- Hatch Eyes Generic Biologics Bill Modeled On E.U. Approach
- Hearing On Neurontin Injunction Closes Without Ruling
- Bausch & Lomb Sues Ocular Sciences Over Contact-Lens Patent
- Pfizer Sues Poland's Top Drug Maker Over Viagra Knockoff
- U.S. Supreme Court Mulls Rare Review Of Patent Case
- AstraZeneca Loses Battle Against Generic Plendil At Federal Circuit
- Merck Sues Dr. Reddy's Over ANDA For Propecia Generic
- Akzo Nobel Settles Antitrust Litigation Over Remeron Patents For $59.8M
- CollaGenix Sues Over ANDAs For Periostat Generics
- Glaxo Faces Another Antitrust Suit Over Relafen Patent